Walleye Capital’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$116K Buy
+600
New +$74.1K ﹤0.01% 5120
2024
Q3
– Sell
-1,013
Closed -$49.9K – 5892
2024
Q2
$49.9K Buy
+1,013
New +$41.3K ﹤0.01% 4928
2023
Q2
– Sell
-81,939
Closed -$1.23M – 4893
2023
Q1
$1.24M Buy
+81,939
New +$1.81M 0.02% 1012
2022
Q1
– Sell
-3,091
Closed -$239K – 2603
2021
Q4
$239K Buy
+3,091
New +$317K 0.01% 1375
2021
Q2
– Sell
-3,192
Closed -$395K – 1512
2021
Q1
$395K Sell
3,192
-763
-19% -$116K 0.02% 673
2020
Q4
$559K Buy
+3,955
New +$439K 0.04% 450

Other funds holding TWST

Walleye Capital's TWST Position: Q3 2026 in Review

Walleye Capital opened a new position in Twist Bioscience (TWST) in Q3 2026: 600 shares worth $116K. The stake represents ﹤0.01% of the portfolio and ranks #5120 among its holdings. This is a return to the name: Walleye Capital previously reported a position in TWST as recently as Q2 2024.

Walleye Capital first reported a position in TWST in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.24M in Q1 2023. 433 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Walleye Capital held 600 shares of Twist Bioscience worth $116K as of Q3 2026.
  • Twist Bioscience was a new Walleye Capital position in Q3 2026.
  • Twist Bioscience made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5120 holding.
  • Walleye Capital first reported a position in Twist Bioscience in Q4 2020 and has held it in 6 quarters since.
  • Walleye Capital's Twist Bioscience position peaked at $1.24M in Q1 2023.
  • 433 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.